(Total Views: 390)
Posted On: 02/03/2020 4:41:40 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Cytodynamite #16722
This is much better than $.50 purchase price, 125% warrant coverage, $.30 exercise price....yes its dilution, but much more favorable than previous rounds. Plus this could very likely go to pay the noteholder off that is getting $.50/shares monthly and selling as fast as they can and constantly putting pressure on the share price. I suspect this is to not get caught in the jam the noteholder put them in around New Year when they converted a several months worth all at once and CYDY didn't have the cash available.....likely when management was trying to take a few days off over the holidays.
As long as they don't request increase to AS, I'm not concerned of this impacting non-dilutive financing that is likely in the works.
As long as they don't request increase to AS, I'm not concerned of this impacting non-dilutive financing that is likely in the works.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.